https://www.indianpharmapost.com/takara-bio-europe-unveils-new-large-scale-ngs-profiling-system-and-chemistries-162332024-09-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/sanofis-dupixent-approved-in-the-us-as-the-first-ever-biologic-medicine-for-patients-with-copd-162462024-09-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/usv-launches-q-rite-tablets-for-treatment-of-rare-aprhythmia-in-heart-patients-162452024-09-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/briefs-krsnaa-diagnostics-and-anuh-pharma-162442024-09-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/alembic-receives-usfda-final-approval-for-paliperidone-er-tablets-162432024-09-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/alkem-denies-claims-of-pan-d-clavam-625-batches-being-substandard-quality-162422024-09-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-and-csir-cdri-lucknow-to-develop-drug-for-ckd-induced-osteoporosis-162412024-09-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/rockwell-study-highlights-need-for-highly-skilled-workforce-for-life-sciences-162402024-09-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/india-highlights-need-for-global-cooperation-to-address-amr-threat-at-unga-162392024-09-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/avient-expands-healthcare-tpu-manufacturing-in-china-162382024-09-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/krsnaa-diagnostics-acquires-stake-in-apulki-healthcare-162372024-09-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/sun-pharma-presents-clinical-efficacy-and-safety-data-in-severe-dermatological-conditions-at-2024-eadv-congress-162362024-09-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/torrent-pharmaceuticals-refutes-claims-of-shelcal-500-allegedly-failing-cdsco-quality-test-162352024-09-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/biocon-partners-with-tabuk-to-commercialize-its-glucagon-like-peptide-1-products-in-the-middle-east-162342024-09-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/bluerock-therapeutics-investigational-cell-therapy-bemdaneprocel-for-parkinsons-disease-shows-positive-data-at-24-months-162472024-09-27T00:00:00+05:30always0.9